Jamie has over 20 years’ experience in the patent profession, working both in private practise and in-house. He specialises in the field of chemistry, particularly medical devices, pharmaceuticals and performance chemicals.
As well as drafting and prosecuting patent applications and managing global patent portfolios, he handles contentious EPO opposition and appeal proceedings having gained significant experience whilst living and working in Munich. Jamie also provides strategic advice on IP portfolios, and opinions on the infringement and validity of patents.
B. Sc. (Hons) Chemistry, First Class, University of St Andrews
Ph. D. (Chemistry), University of St Andrews
"In Edinburgh, Jamie Thomson manages global patent portfolios in the fields of medical devices, pharmaceuticals and performance chemicals. He is also no stranger to oppositions and appeals at the EPO, having gained abundant experience in the area over two years stationed in Munich."
Jamie sits on the Law Society of Scotland’s IP sub-committee, which reviews new IP legislation effecting Scotland.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.